Skip to content

Mind Body Syndrome Therapy for Chronic Pain

Mind Body Syndrome Therapy for the Treatment of Chronic Pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04689646
Enrollment
150
Registered
2020-12-30
Start date
2021-05-20
Completion date
2027-06-01
Last updated
2026-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Chronic Pain Syndrome

Brief summary

The goal of this study is to determine if a mind-body intervention can help people suffering from chronic back pain. The study is a randomized, partially blinded trial examining the effectiveness of a mind body intervention in reducing disability from back pain and alleviating back pain in participants as compared to usual care and an active control (second mind body intervention). The investigators will secondarily investigate whether the intervention alleviates anxiety related to the pain and other quality of life parameters.

Detailed description

The goal of this study is to determine if a mind-body intervention can help people suffering from chronic back pain. The study is a randomized, partially blinded trial examining the effectiveness of a mind body intervention in reducing disability from back pain and alleviating back pain in participants as compared to usual care (control arm) and an active control arm. The investigators will secondarily investigate whether the intervention alleviates anxiety related to the pain and other quality of life parameters.

Interventions

BEHAVIORALMind Body Intervention 1

Mind body techniques for Intervention 1 will be taught in lectures and group discussion sessions.

Mind body techniques for Intervention 2 will be taught in lectures and group and/or individual sessions.

Sponsors

Beth Israel Deaconess Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Double (Participant, Outcomes Assessor) Participants will be partially blinded. Participants in the usual care arm will be blinded to the specifics of the interventions. Participants in Mind-Body Intervention 2 arm will be blinded to the specifics of the interventions. Intervention participants will be blinded to the specifics of the intervention until after they have been randomized into that arm. Data analysis will be conducted by persons who are completely blinded.

Intervention model description

Mind-Body Intervention 1, Mind-Body Intervention 2 and Usual Care

Eligibility

Sex/Gender
ALL
Age
18 Years to 67 Years
Healthy volunteers
No

Inclusion criteria

* Adult patient 18 ≥ years old * Chronic back pain * Pain persistent for a minimum of 3 days a week for the past three months prior to enrollment * Willingness to consider mind-body intervention * At least score of 2 or more on Roland Disability Questionnaire * At least score of 3 or more back pain bothersomeness

Exclusion criteria

* Patients \< 18 years of age * Patients \> 67 years of age * Diagnosed organic disease as cause of pain, such as (but not limited) to malignancy, neurologic disorder (i.e., amyotrophic lateral sclerosis), cauda equina syndrome (note that pain related to disc disease is not an exclusion unless there are neurological impairments) * Patients with a diagnosis of significant psychiatric co-morbidities such as schizophrenia, dementia, and bipolar disorder

Design outcomes

Primary

MeasureTime frameDescription
Pain Disability26 weeksRoland Morris Disability Index (Scale 0-24 with 24 being worst)

Secondary

MeasureTime frameDescription
Average painBaseline, 4, 8, 13, and 26 weeks after initiation of the study.Average pain as determined in the Brief Pain Inventory Survey (Scale 0-10 with 10 being worst)
Pain Bothersomeness (Back Specific): Brief Pain Inventory SurveyBaseline, 4 weeks, 8 weeks, 13 weeks, 26 weeksBack pain bothersomeness as determined from modified Brief Pain Inventory Survey. (Scale 0-10 with 10 being the worst
Anxiety from painBaseline, 4 weeks, 8 weeks, 13 weeks, 26 weeksAnxiety from pain as determined from the Pain Anxiety Symptom Scale-20 survey (20 questions with scale of 0-5 with 5 being 'always' and 0 being 'never'
Resolution of pain disabilityBaseline, 4 weeks, 8 weeks, 13 weeks, 26 weeksResolution of pain disability as measured by 0 or 1 on Roland Morris Disability (Scale 0-24 with 24 being worst)
Pain affecting enjoyment of lifeBaseline, 4 weeks, 8 weeks, 13 weeks, 26 weeksScale 0-10 with 10 being worst from Brief Pain Inventory
Resolution of back pain bothersomenessBaseline, 4 weeks, 8 weeks, 13 weeks, 26 weeksResolution of back pain bothersomeness as measured as 0-1 on scale 0-10

Countries

United States

Contacts

CONTACTSamuel Kukler, BA
skukler@bidmc.harvard.edu617-754-2885
CONTACTMichael Donnino, MD
mdonnino@bidmc.harvard.edu617-754-2885
PRINCIPAL_INVESTIGATORMichael Donnino, MD

Beth Israel Deaconess Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026